Medical Device Network on MSN
Alcon spends up to $200M to co-develop customisable cataract lenses with RxSight
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
Alcon's $200M RxSight partnership aims to recapture IOL market share with adjustable presbyopic lenses. RxSight gets 30% ...
Alcon and RxSight announced a nonexclusive collaboration to develop a light-adjustable presbyopia-correcting IOL, according ...
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...
With the full U.S. availability of TECNIS PureSee IOL, we are expanding access to an important extended depth of focus option ...
Celebrating 75 years of intraocular lens advancements that have improved care for millions of cataract patients. On November 29, 1949, Sir Harold Ridley performed a surgical procedure to replace a ...
Johnson & Johnson (NYSE:JNJ) is one of the best stocks for beginners to buy now. On June 11, Johnson & Johnson expanded the ...
Among children who underwent unilateral cataract removal in infancy, risk of glaucoma-related adverse events continues to increase with longer follow-up and is not associated with primary intraocular ...
Children with bilateral uneven cataracts who needed bilateral cataract surgery were prospectively enrolled in Oxford Eye Center, Johannesburg, South Africa and Southwest Eye Hospital, Chong Qing, ...
Please provide your email address to receive an email when new articles are posted on . Pediatric cataract continues to be a leading cause of childhood blindness. Early detection of pediatric ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results